Technology Archives - Halberd Corporation

Oct 27 2025

Halberd Corporation Successfully Demonstrates its Proprietary Breakthrough AI Technology for Behavioral Analysis Platform

By Admin|2025-10-25T17:19:11-04:00October 27th, 2025|Featured, Investor News, Press Releases, Technology|0 Comments

Live Technical Demonstration Validates NeuroSense AI Platform Feasibility; Development Moves Forward with Proven Core Technologies Jackson Center, PA – October 27, 2025 – Halberd Corporation (OTC: HALB) today announced the successful completion of a technical feasibility demonstration for NeuroSense AI, its proprietary behavioral intelligence platform in development. The live demonstration, conducted Thursday before key stakeholders, ...

Aug 26 2024

Halberd Corp. – Taking a Moment to Recenter Our Technical Progress

By Admin|2024-08-29T16:41:51-04:00August 26th, 2024|Investor News, Press Releases, Technology, Update Letter|0 Comments

Introducing Tri-axTM TBI Nasal Spray Treatment- the DoD selected our MSU-led pre-proposal, inviting us to submit a full application/proposal Jackson Center, PA August 26, 2024 – Halberd Corporation (OTC-PINK: "HALB”) This is the first of a series of three significant Press Releases we plan to issue shortly. Many of our investors have been voicing concern ...

May 22 2024

Halberd/Athena GTX Research Promises a Much Brighter Future

By Admin|2024-05-21T16:43:28-04:00May 22nd, 2024|Featured, Investor News, News, Press Releases, Technology|0 Comments

Walt Disney once said, “All our dreams can come true if we have the courage to pursue them”. Jackson Center, PA May 22, 2024 – Halberd Corporation (OTC-PINK: "HALB”) in cooperation with Athena GTX, Inc is standing at the threshold of some major advancements to treat the issues facing not only our military but people ...

Sep 3 2020

MoneyTV Interview With Donald Baillargeon

By Admin|2020-09-03T14:47:01-04:00September 3rd, 2020|Investor News, News, Technology, Videos|0 Comments

On MoneyTV with Donald Baillargeon, Halberd Corporation CEO William Hartman explained why they chose Arizona State University as their research partner.

Aug 27 2020

Halberd Corporation Selects University Research Partner

By Admin|2020-08-27T08:00:21-04:00August 27th, 2020|Featured, News, Technology|0 Comments

Jackson Center, PA, August 27, 2020 – Halberd Corp. (OTC PINK: "HALB") is pleased to announce the successful completion of its search for a major research university partner. The University, to be announced, is engaged to develop compounds for use in Halberd’s patented extracorporeal treatment of Covid-19. Terms of the agreement have been finalized and ...

Aug 18 2020

Halberd Corporation CEO Answers Shareholders’ Questions Regarding Covid-19 Treatment

By Admin|2020-08-18T08:00:11-04:00August 18th, 2020|Featured, Investor News, News, Technology|0 Comments

Jackson Center, PA, August 18, 2020 – Halberd Corp. (OTC PINK: "HALB") Chairman, President & CEO of Halberd Corporation, William A. Hartman, has received a number of questions from shareholders regarding the extracorporeal process for treatment of Covid-19. Below, Mr. Hartman responds to those questions. Q: There are various extracorporeal medical procedures being researched or ...

Jul 7 2020

COVID-19 Cytokine Storm, Coronavirus’ Deadliest Stage – Halberd’s US Patent Pending Treatment Now Explained!

By Admin|2020-07-06T19:47:51-04:00July 7th, 2020|Featured, News, Technology|0 Comments

Jackson Center, PA, July 7, 2020 – Halberd Corp. (OTC PINK: "HALB") today explains the second of three (3) COVID -19 (Coronavirus) patent pending treatments - “Method for Treating Covid-19 Inflammatory Cytokine Storm for the Reduction of Morbidity and Mortality in Covid-19 Patients” - which was filed with the U.S. Patent and Trademark Office on ...

Jun 29 2020

Halberd Method for Treating and Curing the COVID-19 Infection Explained

By Admin|2020-06-28T19:55:51-04:00June 29th, 2020|Featured, News, Technology|0 Comments

Jackson Center, PA, June 29, 2020 – Halberd Corporation (OTC-PINK: "HALB") today unveils the first of three (3) COVID -19 (Coronavirus) patent pending treatment methods -- the first titled, “Method for Treating and Curing Covid-19 Infection” -- filed with the U.S. Patent and Trademark Office on March 16, 2020. Halberd holds exclusive worldwide license to ...

Jun 22 2020

NFL Retired Players Association’s Chief Medical Officer Joins Halberd Corporation to Lead COVID-19 Efforts

By Admin|2020-06-21T20:27:29-04:00June 22nd, 2020|Featured, News, Technology|0 Comments

Effective Immediately! Jackson Center, PA, June 22, 2020 – Halberd Corporation (OTC Pink: HALB) announced the appointment of Dr. Patricio F. Reyes to the position of Chief Technical Officer effective immediately. He will report to Halberd’s new Chairman, President and CEO, William A. Hartman and is currently the Chief Medical Officer of the NFL’s Retired ...

Jun 15 2020

Halberd Designated “Pink Current Information” by OTC and Continues Technology Progress

By Admin|2020-06-21T04:55:39-04:00June 15th, 2020|Featured, News, Technology|0 Comments

Jackson Center, PA, June 15, 2020 –Halberd Corporation (OTC Pink: HALB) announced that OTC Markets has completed its background investigation and analysis of all filings by Halberd Corporation and now designates Halberd Corporation as "Pink Current Information". William A. Hartman, newly appointed Chairman, President and CEO explains, “Now that Halberd has been designated by OTC ...

12 Next